Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Recent advances in diagnosis and management of Mycotic Keratitis.

Maharana PK, Sharma N, Nagpal R, Jhanji V, Das S, Vajpayee RB.

Indian J Ophthalmol. 2016 May;64(5):346-57. doi: 10.4103/0301-4738.185592. Review.

2.

Design and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application.

Khare A, Singh I, Pawar P, Grover K.

J Drug Deliv. 2016;2016:6590361. doi: 10.1155/2016/6590361.

3.

Actinobacillus actinomycetemcomitans Keratitis After Glaucoma Infiltration Surgery: A Clinical Report and Literature Review.

Hong J, Xu J, Cao W, Ji J, Sun X.

Medicine (Baltimore). 2016 Jan;95(3):e2608. doi: 10.1097/MD.0000000000002608. Review.

4.

Dectin-1 agonist curdlan modulates innate immunity to Aspergillus fumigatus in human corneal epithelial cells.

Zhu CC, Zhao GQ, Lin J, Hu LT, Xu Q, Peng XD, Wang X, Qiu S.

Int J Ophthalmol. 2015 Aug 18;8(4):690-6. doi: 10.3980/j.issn.2222-3959.2015.04.09.

5.

Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis.

Qiu S, Zhao GQ, Lin J, Wang X, Hu LT, Du ZD, Wang Q, Zhu CC.

Int J Ophthalmol. 2015 Jun 18;8(3):597-602. doi: 10.3980/j.issn.2222-3959.2015.03.29.

6.

Early diagnosis and successful treatment of Cryptococcus albidus keratitis: a case report and literature review.

Huang YH, Lin IH, Chang TC, Tseng SH.

Medicine (Baltimore). 2015 May;94(19):e885. doi: 10.1097/MD.0000000000000885.

7.

Effectiveness of posaconazole in recalcitrant fungal keratitis resistant to conventional antifungal drugs.

Altun A, Kurna SA, Sengor T, Altun G, Olcaysu OO, Aki SF, Simsek MH.

Case Rep Ophthalmol Med. 2014;2014:701653. doi: 10.1155/2014/701653.

8.

Evaluation of fungal keratitis using a newly developed computer program, Optscore, for grading digital corneal photographs.

Toutain-Kidd CM, Porco TC, Kidd EM, Srinivasan M, Prajna NV, Acharya N, Lietman T, Zegans ME.

Ophthalmic Epidemiol. 2014 Feb;21(1):24-32. doi: 10.3109/09286586.2013.868003.

9.

In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Lalitha P, Sun CQ, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Cevallos V, McLeod SD, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group..

Am J Ophthalmol. 2014 Feb;157(2):318-26. doi: 10.1016/j.ajo.2013.10.004.

10.

Current Thoughts in Fungal Keratitis: Diagnosis and Treatment.

Ansari Z, Miller D, Galor A.

Curr Fungal Infect Rep. 2013 Sep 1;7(3):209-218.

11.

Voriconazole for fungal keratitis.

Prajna NV, O'Brien KS, Acharya NR, Lietman TM.

Ophthalmology. 2013 Sep;120(9):e62-3. doi: 10.1016/j.ophtha.2013.06.016. No abstract available.

12.

Differences in clinical outcomes in keratitis due to fungus and bacteria.

Prajna NV, Srinivasan M, Lalitha P, Krishnan T, Rajaraman R, Ravindran M, Mascarenhas J, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM.

JAMA Ophthalmol. 2013 Aug;131(8):1088-9. doi: 10.1001/jamaophthalmol.2013.1612. No abstract available.

13.

Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.

Pawar P, Kashyap H, Malhotra S, Sindhu R.

Biomed Res Int. 2013;2013:341218. doi: 10.1155/2013/341218.

14.

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.

Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, Raghavan A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Porco TC, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group..

JAMA Ophthalmol. 2013 Apr;131(4):422-9.

15.

Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.

Sun CQ, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Acharya NR, Lietman TM.

Invest Ophthalmol Vis Sci. 2013 Jun 14;54(6):4167-73. doi: 10.1167/iovs.13-11716.

16.

Diversity of microbial species implicated in keratitis: a review.

Karsten E, Watson SL, Foster LJ.

Open Ophthalmol J. 2012;6:110-24. doi: 10.2174/1874364101206010110.

17.

Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.

Prajna VN, Lalitha PS, Mascarenhas J, Krishnan T, Srinivasan M, Vaitilingam CM, Oldenburg CE, Sy A, Keenan JD, Porco TC, Acharya NR, Lietman TM.

Br J Ophthalmol. 2012 Nov;96(11):1440-1. doi: 10.1136/bjophthalmol-2012-301825. No abstract available.

18.

Antifungal efficacy of natamycin in experimental fusarium solani keratitis.

Dong XH, Gao WJ, He XP.

Int J Ophthalmol. 2012;5(2):143-6. doi: 10.3980/j.issn.2222-3959.2012.02.05.

19.

Predictors of outcome in fungal keratitis.

Prajna NV, Krishnan T, Mascarenhas J, Srinivasan M, Oldenburg CE, Toutain-Kidd CM, Sy A, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Porco TC.

Eye (Lond). 2012 Sep;26(9):1226-31. doi: 10.1038/eye.2012.99.

20.

Fungal antioxidant pathways promote survival against neutrophils during infection.

Leal SM Jr, Vareechon C, Cowden S, Cobb BA, Latgé JP, Momany M, Pearlman E.

J Clin Invest. 2012 Jul;122(7):2482-98. doi: 10.1172/JCI63239.

Items per page

Supplemental Content

Support Center